FLAWED, SCANDALOUS TRIALS TANK FDA EXPERT SUPPORT FOR MDMA THERAPY

Summary from the TLDR newsletter

Advisors for the Food and Drug Administration have voted overwhelmingly against approving MDMA as part of a therapy for post-traumatic stress disorder. While results from clinical trials showed positive results, a deeper look at the data uncovered a large number of trial flaws that threw the validity of the positive results into serious question. The FDA is conducting an investigation into accusations of possible data manipulation during the trials. There were claims that some of the trial participants were discouraged from reporting negative responses to the therapy.